William Wierda on Treatment of CLL in Young and Elderly Patients

Article

William Wierda, MD, PhD, medical director, Leukemia Center, The University of Texas MD Anderson Cancer Center, discusses treatment of chronic lymphocytic leukemia (CLL) in young and elderly patients.

William Wierda, MD, PhD, medical director, Leukemia Center, The University of Texas MD Anderson Cancer Center, discusses treatment of chronic lymphocytic leukemia (CLL) in young and elderly patients.

Older patients with CLL tend to have lower tolerance of some chemotherapies than younger patients because they have more illnesses or are taking more medications.

Wierda says that recent trials show promising results of more effective treatments than chemotherapy for CLL.

Wierda adds that patient age will become less relevant as a prognostic factor as new therapies emerge.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Recent Videos
3 KOLs are featured in this series.
3 KOLs are featured in this series.
Image of a woman with blond hair wearing a headset and a hospital badge over a blouse in front of a watercolor Oncology Nursing News background
© 2025 MJH Life Sciences

All rights reserved.